EDGAR Filing Documents for 9999999995-19-001379

Form EFFECT - Notice of Effectiveness:

SEC Accession No. 9999999995-19-001379

Accepted

2019-06-20 00:15:45

Documents

Effectiveness Date

2019-06-19

Registration Form

S-1

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	EFFECT
1		primary_doc.xml	EFFECT	595
	Complete submission text file	9999999995-19-001379.txt		1686

Mailing Address 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016

Business Address 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016 917-336-9310

Prevail Therapeutics Inc. (Filer) CIK: 0001714798 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: EFFECT | Act: 33 | File No.: 333-231754 | Film No.: 19907403
SIC: 2836 Biological Products, (No Diagnostic Substances)